Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Danhof

Showing results (91-100 of 250) with videos related to

Pageof 25
Sort By:
British Journal of Pharmacology|February 1, 1995
Pharmacokinetic modelling of the haemodynamic effects of the A2a adenosine receptor agonist CGS 21680C in conscious normotensive ratsR A Mathôt, A Cleton, W Soudijn, et al.
British Journal of Pharmacology|May 22, 2008
Pharmacokinetic-pharmacodynamic modelling of fluvoxamine 5-HT transporter occupancy in rat frontal cortexM Geldof, J I Freijer, L van Beijsterveldt, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 7, 1998
Pharmacokinetic-pharmacodynamic modeling of the anticonvulsant and electroencephalogram effects of phenytoin in ratsO E Della Paschoa, J W Mandema, R A Voskuyl, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 13, 1998
Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of synthetic opioids in the rat: correlation with the interaction at the mu-opioid receptorE H Cox, T Kerbusch, P H Van der Graaf, et al.
Pharmaceutisch Weekblad. Scientific Edition|December 11, 1992
Drug transport across the blood-brain barrier. II. Experimental techniques to study drug transportJ B Van Bree, A G De Boer, M Danhof, et al.
British Journal of Pharmacology|August 1, 1995
Modelling of the pharmacodynamic interaction of an A1 adenosine receptor agonist and antagonist in vivo: N6-cyclopentyladenosine and 8-cyclopentyltheophyllineS Appel, R A Mathôt, M W Langemeijer, et al.
Pharmaceutical Research|November 26, 1999
Mechanism-based modeling of adaptive changes in the pharmacodynamics of midazolam in the kindling model of epilepsyA Cleton, P H Van der Graaf, W Ghijsen, et al.
Pharmacy World & Science : PWS|February 19, 1993
Drug transport across the blood-brain barrier. III. Mechanisms and methods to improve drug delivery to the central nervous systemJ B Van Bree, A G De Boer, M Danhof, et al.
British Journal of Pharmacology|May 1, 1996
Pharmacokinetic-haemodynamic relationships of 2-chloroadenosine at adenosine A1 and A2a receptors in vivoR A Mathoôt, W Soudijn, D D Breimer, et al.
British Journal of Clinical Pharmacology|May 1, 1989
The contribution of nisoldipine-induced changes in liver blood flow to its pharmacokinetics after oral administrationJ van Harten, J Burggraaf, M Danhof, et al.
Pageof 25

Showing results (91-100 of 250) with videos related to

Sort By:
Pageof 25
British Journal of Pharmacology|February 1, 1995
Pharmacokinetic modelling of the haemodynamic effects of the A2a adenosine receptor agonist CGS 21680C in conscious normotensive ratsR A Mathôt, A Cleton, W Soudijn, et al.
British Journal of Pharmacology|May 22, 2008
Pharmacokinetic-pharmacodynamic modelling of fluvoxamine 5-HT transporter occupancy in rat frontal cortexM Geldof, J I Freijer, L van Beijsterveldt, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 7, 1998
Pharmacokinetic-pharmacodynamic modeling of the anticonvulsant and electroencephalogram effects of phenytoin in ratsO E Della Paschoa, J W Mandema, R A Voskuyl, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 13, 1998
Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of synthetic opioids in the rat: correlation with the interaction at the mu-opioid receptorE H Cox, T Kerbusch, P H Van der Graaf, et al.
Pharmaceutisch Weekblad. Scientific Edition|December 11, 1992
Drug transport across the blood-brain barrier. II. Experimental techniques to study drug transportJ B Van Bree, A G De Boer, M Danhof, et al.
British Journal of Pharmacology|August 1, 1995
Modelling of the pharmacodynamic interaction of an A1 adenosine receptor agonist and antagonist in vivo: N6-cyclopentyladenosine and 8-cyclopentyltheophyllineS Appel, R A Mathôt, M W Langemeijer, et al.
Pharmaceutical Research|November 26, 1999
Mechanism-based modeling of adaptive changes in the pharmacodynamics of midazolam in the kindling model of epilepsyA Cleton, P H Van der Graaf, W Ghijsen, et al.
Pharmacy World & Science : PWS|February 19, 1993
Drug transport across the blood-brain barrier. III. Mechanisms and methods to improve drug delivery to the central nervous systemJ B Van Bree, A G De Boer, M Danhof, et al.
British Journal of Pharmacology|May 1, 1996
Pharmacokinetic-haemodynamic relationships of 2-chloroadenosine at adenosine A1 and A2a receptors in vivoR A Mathoôt, W Soudijn, D D Breimer, et al.
British Journal of Clinical Pharmacology|May 1, 1989
The contribution of nisoldipine-induced changes in liver blood flow to its pharmacokinetics after oral administrationJ van Harten, J Burggraaf, M Danhof, et al.
Pageof 25